ESNO participation ON THE BIOSIMILAR
Specialist Nurses are increasingly involved with medication and also participate in many activities such as education, clinical trials, design programs and participate in stewardship programs. Here below the activity overview.
ESNO Position Statement on Biosimilar DOWNLOAD
ESNO Focusgroup Biosimilar
Activity: devellop Information and Communication Guideline for Nurses
Members: Diabetes, Rheumatology, Inflammatoy Bowel Diseases, Oncology and Dermatology
Participation in the EMA Biosimilar Medicinal Working Party (BMWP)
Participate in DG Growth Topic meeting.
'ESNO Information and Communication Guideline Biosimilars for Nurses'
Following the EMA Guideline for Healthcare Professionals, and Patients Q&A, ESNO is in the process to develop a guideline with information on biosimilar from the nurses perspective and instuments to communicate with other HCP and patients for an effective use. This guideline is in process and current under review of all stakeholders. The expected publication is April 2018.
EMA Communication on Biosimilars
The EMA interacts with Health Care Professionals. Watch the VIDEO HERE
ESNO participation in DG Sante
Policy: Healthcare is highly labour intensive and one of the largest economic sectors in the EU – accounting for around 17 million jobs (8% of all jobs). Aging populations and rising demand will ensure the healthcare sector remains a key driver for jobs in the future. Despite this, the sector faces major challenges: an aging workforce and too few new recruits to replace retirees significant employee turnover in some fields due to demanding working conditions and relatively low pay the need for new skills to deal with innovative technologies and with the rise in chronic conditions such as diabetes and heart disease among the elderly. Action plan for EU health workforce: The action plan for the EU health workforce – SWD (2012) 93 final(140 KB) seeks to help EU countries work together to tackle these challenges and boost employment by:
• improving health workforce planning and forecasting
• anticipating future skills needs and improving continuous professional development/lifelong learning
• improving recruitment and retention of health professionals
• mitigating the negative effects of migration on health systems
+31 (0)6 2334086
Rue Belliard 15-17 (6th floor)
ESNO is registered with the European Commission Transparency: Registration 70183498905-52
ESNO supports the European Patient Forum Empowerment Campaign
ESNO registration Chamber of Commerce Netherlands number: 32141241
ESNO EUROPEAN SPECIALIST NURSES ORGANISATIONS